Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02619409 · ClinicalTrials.gov registry record · NA
Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash
A NA study of Arthropathy of Knee and Arthropathy of Hip, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02619409: Completed NA study of Arthropathy of Knee and Arthropathy of Hip, sponsored by Medical University of South Carolina.
NCT02619409 is a NA study of Arthropathy of Knee and Arthropathy of Hip that has completed, run by Medical University of South Carolina. The registered enrollment target is 30 participants, below the 89-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02619409, a NA study of Arthropathy of Knee and Arthropathy of Hip, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Bupivacaine spinal is commonly performed as the primary anesthetic for orthopedic procedures. In some cases the duration of the block is inadequate. An epinephrine wash is sometimes performed to prolong the duration of the block. The epinephrine wash may prolong the duration of the block, and if it does, to what extent?
Primary Outcome
Duration of the sensory block at the T12 dermatome will be assessed in the post operative phase
Conditions Studied
Interventions
- DRUG Bupivacaine Only
- DRUG EPI25
- DRUG EPI50 group
- DRUG EPI75 group
- DRUG EPI100 group
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-02-11 |
| Est. Completion | 2016-10-20 |
| Phase | NA |
What the finished NCT02619409 record still lists
NCT02619409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 89-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Arthropathy of Knee appearing as the primary indexed condition, and to 5 interventions - of which Bupivacaine Only is the first listed.
NCT02619409 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02619409 about?
NCT02619409 is a clinical study titled "Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash". Bupivacaine spinal is commonly performed as the primary anesthetic for orthopedic procedures. In some cases the duration of the block is inadequate. An epinephrine wash is sometimes performed to prolong the duration of the block. The epinephrine wash may prolong the duration of the block, and if it ...
What is the current status of trial NCT02619409?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-02-11. Estimated completion is 2016-10-20.
What conditions does trial NCT02619409 study?
This clinical trial studies the following conditions: Arthropathy of Knee, Arthropathy of Hip.
What interventions are being tested in trial NCT02619409?
The interventions under investigation include: Bupivacaine Only (DRUG), EPI25 (DRUG), EPI50 group (DRUG), EPI75 group (DRUG), EPI100 group (DRUG).
Who is sponsoring clinical trial NCT02619409?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02619409 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthropathy of Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nirvana Super Pro Supplementation in Orthopedic Surgery Patients
RECRUITING · NA
-
A Comparison Of Primary TKA Rehabilitation Using A Smart Orthotic Versus Outpatient Physical Therapy
RECRUITING · NA
-
Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
RECRUITING · NA
-
Triathlon All-Polyethylene Tibia Outcomes Study
ACTIVE NOT RECRUITING · NA
-
The Effect of Light Therapy on Post-Surgical Pain
ACTIVE NOT RECRUITING · NA
-
Opioid Education in Total Knee Arthroplasty
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI